Clover Health issued analysis on Clover Assistant, management of diabetes

Clover Health issued an analysis titled Clover Assistant Use and Diagnosis, Treatment, and Progression of Diabetes, which examines the association between use of the company’s flagship technology product, Clover Assistant, and earlier physician identification and management of diabetes. “Early diagnosis and treatment of diabetes in the Medicare population is essential for preventing complications, improving overall health and well being, and reducing the economic burden associated with the condition,” said Dr. Kumar Dharmarajan, Chief Medical Officer of Clover Assistant. “Our findings demonstrate that use of Clover Assistant is associated with not only earlier diabetes diagnosis and treatment with oral diabetes medications, but also lower blood sugar, insulin use, and hypoglycemia, a major insulin-related complication.”